UTI vs LINC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

UTI

53.0
AI Score
VS
UTI Wins

LINC

50.6
AI Score

Investment Advisor Scores

UTI

53score
Recommendation
HOLD

LINC

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UTI LINC Winner
Revenue 442.25M 143.96M UTI
Net Income 13.26M 4.36M UTI
Net Margin 3.0% 3.0% LINC
Operating Income 16.03M 6.41M UTI
ROE 3.9% 2.2% UTI
ROA 1.6% 0.9% UTI
Total Assets 852.18M 486.73M UTI
Cash 87.23M 16.69M UTI
Debt/Equity 0.38 0.03 LINC
Current Ratio 1.17 0.83 UTI
Free Cash Flow -45.59M -10.06M LINC

Relative Price Performance (Last 90 Days)

UTI 1M: -16.4% · 3M: +4.7% LINC 1M: -20.5% · 3M: +1.7%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $39.31

LINC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.1 · Price: $41.82

Fundamentals Snapshot

Metric UTI LINC
Market Cap
Forward P/E 46.2 38.7
Trailing P/E 54.1 58.3
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.74 0.72
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.